<?xml version="1.0" encoding="UTF-8"?>
<GaPExchange xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="./dbGaPEx2.1.5.xsd">

<MetaVariables>
	<Submitter/>
	<Method/>
</MetaVariables>
<MetaLinks/>

<Projects>
	<Project/>
</Projects>

<Studies>

<Study source="dbGaP" accession="phs000641.v1.p1" parentStudy="phs000641.v1.p1" createDate="2013-07-23" modDate="2013-07-29">

<Configuration>
	<Data_Provider><![CDATA[
		<table border="1">
		<tr><th>Title</th><th>Name</th><th>Institute</th></tr>
		<tr><td>Principal Investigator</td><td>Luigi D. Notarangelo, MD</td><td>Division of Immunology, Boston Children&#39;s Hospital; Harvard Stem Cell Institute, Harvard Medical School, Boston, MA, USA</td></tr>
		<tr><td>Principal Investigator</td><td>Michael Snyder, PhD</td><td>Department of Genetics, Stanford University School of Medicine, Palo Alto, CA, USA</td></tr>
		<tr><td>Principal Investigator</td><td>Kari C. Nadeau, PhD</td><td>Department of Pediatrics, Stanford University School of Medicine, Palo Alto, CA, USA</td></tr>
		<tr><td>Funding Source</td><td>5P01AI076210-04</td><td>National Institutes of Health, Bethesda, MD, USA</td></tr>
		<tr><td>Funding Source</td><td>1R01AI00887-01</td><td>National Institutes of Health, Bethesda, MD, USA</td></tr>
		</table>
	]]></Data_Provider>
	<StudyNameEntrez>TTC7A Mutations for Combined Immunodeficiency with Intestinal Atresia</StudyNameEntrez>
	<StudyNameReportPage>Whole Exome Sequencing Identifies <i>TTC7A</i> Mutations for Combined Immunodeficiency with Intestinal Atresia</StudyNameReportPage>
	<StudyTypes>
		<StudyType>Family</StudyType>
	</StudyTypes>
	<Description><![CDATA[
<p>Combined Immunodeficiency with Multiple Intestinal Atresias (CID-MIA) is a rare genetic disorder with the cause previously unknown. Symptoms of CID-MIA include atresias in the small and/or large intestine, as well as immunodeficiency. In this study, we sequenced the whole exome of 5 unrelated CID-MIA patients as well as their healthy family members, and identified deleterious homozygous or compound heterozygous mutations in the gene <i>TTC7A</i> in all the 5 patients, as well as in 3 additional patients with Sanger sequencing. Our findings strongly indicate <i>TTC7A</i> dysfunction to be the cause for CID-MIA.</p>]]>
	</Description>
	<StudyInEx><![CDATA[
<p><b>Inclusion Criteria:</b></p> <p>Families with probands with Combined Immunodeficiency with Multiple Intestinal Atresias (CID-MIA).</p> <p><b>Exclusion Criteria:</b> N. A.</p>]]>
	</StudyInEx>
	<StudyProjects>
		<Project/>
	</StudyProjects>
	<Publications>
		<Publication>
			<Pubmed pmid="23830146"/>
		</Publication>
	</Publications>
	<Attributions>
		<Header title="Principal Investigator">
			<AttName>Luigi D. Notarangelo, MD</AttName>
			<Institution>Division of Immunology, Boston Children&#39;s Hospital; Harvard Stem Cell Institute, Harvard Medical School, Boston, MA, USA</Institution>
		</Header>
		<Header title="Principal Investigator">
			<AttName>Michael Snyder, PhD</AttName>
			<Institution>Department of Genetics, Stanford University School of Medicine, Palo Alto, CA, USA</Institution>
		</Header>
		<Header title="Principal Investigator">
			<AttName>Kari C. Nadeau, PhD</AttName>
			<Institution>Department of Pediatrics, Stanford University School of Medicine, Palo Alto, CA, USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>5P01AI076210-04</AttName>
			<Institution>National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>1R01AI00887-01</AttName>
			<Institution>National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>4U54AI082973-04</AttName>
			<Institution>National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
	</Attributions>
	<DisplayPublicSummary>yes</DisplayPublicSummary>
	<ConsentGroups>
		<ConsentGroup groupNum="1" shortName="GRU-IRB" longName="General Research Use (IRB)"/>
	</ConsentGroups>
</Configuration>

  <AuthorizedAccess>
    <DacInfo ssDacId="0">
      <DacName>NIAID</DacName>
      <DacFullName>NIAID DAC</DacFullName>
      <DacEmail>0</DacEmail>
      <DacPhone></DacPhone>
      <DacUrl></DacUrl>
    </DacInfo>
    <Policy Policy_ID="phs000641.v1.p1_policy" ref_ssDacId="0">
      <DisplayResearchStatement>yes</DisplayResearchStatement>
      <DisplayPublicSummary>yes</DisplayPublicSummary>
      <EmbargoLength>12</EmbargoLength>
      <YearsUntilRenewal>1</YearsUntilRenewal>
      <WeeksCancelRequest>8</WeeksCancelRequest>
      <PdfSupplementReqired>yes</PdfSupplementReqired>
      <AcknowledgementText>
        <para>
          http://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000641.v1.p1
        </para>
      </AcknowledgementText>
      <DocumentSet>
        <DataUseCertificate Label="Data Use Certificate" FilePath="https://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000641.v1.p1" FileName="DUC-SnyderNadeauNotarangelo.pdf"/>
      </DocumentSet>
    </Policy>
    <ConsentGroups>
      <ParticipantSet groupNum-REF="1">
        <ConsentName>General Research Use (IRB)</ConsentName>
        <ConsentAbbrev>GRU-IRB</ConsentAbbrev>
        <UseLimitation>Use of the data is limited only by the terms of the model Data Use Certification. Requestor must provide documentation of local IRB approval.</UseLimitation>
        <IrbRequired>Yes</IrbRequired>
      </ParticipantSet>
    </ConsentGroups>
  </AuthorizedAccess>


</Study>

</Studies>

</GaPExchange>
